Watertown Bio

Kestrel's $1.45 billion AbbVie Deal, FDA Approves First Ever PROTAC, and Werewolf Breaks Arsenal Lease.

Plus more details on Windgap's big pharma partnership and a number of people moves.

Watertown Bio Journal Club - Posterpalooza

Two big conferences last month generated a flurry of posters from Watertown biotechs

ALS TDI moves to Arsenal Yards, Windgap Medical’s Big Pharma Collab, and Watertown’s Q1 fundraising numbers

Plus Addgene’s rebrand and Earth Day clean ups

C4's Partnership with Roche, Gilead Options Kymera degrader, and Astellas Licenses Dyno Capsid.

Plus the initial dosing of Enanta and Avencell's Clinical Trials

Watertown Bio Journal Club - Improving Vaccine Immunogenicity with Corner Therapeutics

the very model of a modern adjuvant general

Triveni's New Digs, 99 Coolidge's Tenant Bonanza, and Remix's FDA Fast Track Designation

Plus Addgenes' new partnership, and Neumora and Acrivon's cash flow updates

Parallel Bio's Expansion into Therapeutics, and We're Looking Out for More Potential Cash Flow Challenges -Watertown Bio News RoundUp

Plus, where key opinion leaders see Watertown's biotech sector heading.

Watertown Journal Club - Exploring the oRNA behind ORNA Therapeutics